Relating to liability shield products
HB 4643 establishes regulatory requirements for "liability shield products" (medical, pharmaceutical, biological, or technological products already immune from federal liability). It requires manufacturers to conduct five-year placebo-controlled studies, track adverse outcomes using West Virginia's health network and VAERS, and publish safety data publicly. The bill grants individuals the right to refuse these products and imposes civil penalties of up to $100,000 per violation for noncompliance with study, reporting, or refusal requirements. Enforcement begins January 1, 2032, with the Attorney General or affected individuals able to pursue legal action. This applies directly to manufacturers distributing such products in West Virginia.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 21, 2026
Last action Jan 21, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
2
Jan 21, 2026
Committee
To House Judiciary
lower
Jan 21, 2026
Introduced
Introduced in House
lower
Jan 21, 2026
Committee
To Judiciary then Finance
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Evan Worrell
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 4643
Scope: WV
Hi! I can help you understand HB 4643. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline